TrialJournal of neurology2017

Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing-remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study).

Giancarlo Comi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.